Preferences for Methadone Clinics Among Drug Users in Vietnam: a Comparison Between Public and Private Models

Overview

Journal Harm Reduct J

Publisher Biomed Central

Specialties Pharmacology
Psychiatry

Date 2020 Jan 8

PMID 31906957

Citations 1

Authors

Tuan Anh Le

Tuan Anh Nguyen

Anh Duc Dang

Cuong Tat Nguyen

Hai Thanh Phan

Giang Thu Vu

Trang Huyen Thi Nguyen

Carl A Latkin

Cyrus S H Ho

Roger C M Ho

Bach Xuan Tran

Jiangbo Ying

Melvyn W B Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Methadone maintenance treatment (MMT) has been proven to be effective in treating opioid dependence. In Vietnam, MMT services are provided primarily by public clinics, with only one private MMT clinic established in recent years. Assessing the preferences of patients for different MMT models is important in evaluating the feasibility of these models. This study measured the preferences of drug users enrolling in public and private MMT clinics in Vietnam and examines the related factors of these preferences.

Methods: A cross-sectional study was performed on 395 participants at 3 methadone clinics in Nam Dinh. Data about the preferences for MMT models and sociodemographic characteristics of participants were collected. Exploratory factor analysis was employed to explore the construct validity of the questionnaire. The chi-square test and Mann-Whitney test were used for analyzing demographic characteristics and preferences of participants. Multivariate logistic regression identified factors associated with participants' preferences.

Results: Half the participants received MMT treatment in a private facility (49.4%). Two preference dimensions were defined as "Availability and convenience of service" and "Competencies of clinic and health professionals". Self-employed patients were more likely to consider these two dimensions when choosing MMT models. Only 9.9% of participants chose "Privacy" as one of the evaluation criteria for an MMT facility. Compared to public clinics, a statistically higher percentage of patients in the private clinic chose the attitudes of health workers as the reason for using MMT service (34.7% and 7.6% respectively). Mean score of satisfaction towards MMT services was 8.6 (SD = 1.0), and this score was statistically higher in a public facility, compared to the private facility (8.7 and 8.4 respectively).

Conclusions: The study highlighted patterns of patient preferences towards MMT clinics. Compared to the public MMT model, the private MMT model may need to enhance their services to improve patient satisfaction.

Citing Articles

A Social History of Opioids' Crimedical Cycle.

Ezell J, Rains A, Patrick Ajayi B, Miller K, Augustine E, Goddard-Eckrich D Addict Res Theory. 2025; 32(6):446-454.

PMID: 39980833 PMC: 11841812. DOI: 10.1080/16066359.2023.2282528.

Predictors for recurrence of drug use among males on probation for methamphetamine use in Japan: a one-year follow-up study.

Takano A, Takahashi K, Anzai T, Usami T, Tsutsumi S, Kanazawa Y Drug Alcohol Depend Rep. 2025; 14:100316.

PMID: 39867467 PMC: 11757224. DOI: 10.1016/j.dadr.2024.100316.

Abortion and contraception within prison health care: a qualitative study.

Paynter M, Heggie C, McLeod A, Norman W BMC Womens Health. 2025; 25(1):34.

PMID: 39849511 PMC: 11755924. DOI: 10.1186/s12905-024-03523-z.

Disproportionate, differential and targeted treatment: people who use drugs' experiences of policing during the COVID-19 pandemic.

Walker S, Rathnayake K, Dietze P, Higgs P, Ward B, Hellard M Health Justice. 2025; 13(1):6.

PMID: 39847147 PMC: 11756195. DOI: 10.1186/s40352-024-00314-4.

Community pharmacy's role in dispensing androgens and supporting harm reduction amid current policy dilemmas.

Piatkowski T, Ayurzana L, King M, Hattingh L, McMillan S Subst Abuse Treat Prev Policy. 2025; 20(1):2.

PMID: 39827172 PMC: 11748596. DOI: 10.1186/s13011-025-00636-y.

References

Tran B, Nguyen L . Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS. Int J Drug Policy. 2013; 24(6):e105-10. DOI: 10.1016/j.drugpo.2013.07.007. View

Hogan B, Hershey L, Ritchey S . A case study using a patient satisfaction survey to improve the delivery and effectiveness of drug addiction treatment services: marketing implications and organizational impact. Health Mark Q. 2008; 24(1-2):93-106. DOI: 10.1080/07359680802125923. View

Kelly S, OGrady K, Brown B, Mitchell S, Schwartz R . The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010; 36(3):150-4. PMC: 2938880. DOI: 10.3109/00952991003736371. View

Caplehorn J . A comparison of private and public methadone maintenance patients. Drug Alcohol Rev. 1992; 11(1):43-9. DOI: 10.1080/09595239200185071. View

Drainoni M, Farrell C, Sorensen-Alawad A, Palmisano J, Chaisson C, Walley A . Patient perspectives of an integrated program of medical care and substance use treatment. AIDS Patient Care STDS. 2014; 28(2):71-81. PMC: 3926137. DOI: 10.1089/apc.2013.0179. View

Hammett T, Wu Z, Duc T, Stephens D, Sullivan S, Liu W . 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction. 2007; 103(1):137-45. DOI: 10.1111/j.1360-0443.2007.02053.x. View

Nguyen T, Nguyen L, Pham M, Vu H, Mulvey K . Methadone maintenance therapy in Vietnam: an overview and scaling-up plan. Adv Prev Med. 2012; 2012:732484. PMC: 3512212. DOI: 10.1155/2012/732484. View

Tran B, Duong A, Nguyen L, Hwang J, Nguyen B, Nguyen Q . Financial burden of health care for HIV/AIDS patients in Vietnam. Trop Med Int Health. 2012; 18(2):212-8. DOI: 10.1111/tmi.12032. View

Tran B . Willingness to pay for methadone maintenance treatment in Vietnamese epicentres of injection-drug-driven HIV infection. Bull World Health Organ. 2013; 91(7):475-82. PMC: 3699795. DOI: 10.2471/BLT.12.115147. View

10.

Herman M, Gourevitch M . Integrating primary care and methadone maintenance treatment: implementation issues. J Addict Dis. 1997; 16(1):91-102. DOI: 10.1300/J069v16n01_06. View

11.

Tran B, Ohinmaa A, Duong A, Do N, Nguyen L, Mills S . Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. AIDS Care. 2011; 24(3):283-90. DOI: 10.1080/09540121.2011.608420. View

12.

SIMPSON D, Joe G, Greener J . Drug abuse treatment process components that improve retention. J Subst Abuse Treat. 1998; 14(6):565-72. DOI: 10.1016/s0740-5472(97)00181-5. View

13.

Zhang Z, Gerstein D, Friedmann P . Patient satisfaction and sustained outcomes of drug abuse treatment. J Health Psychol. 2008; 13(3):388-400. PMC: 2796692. DOI: 10.1177/1359105307088142. View

14.

Lan C, Lin C, Thanh D, Li L . Drug-related stigma and access to care among people who inject drugs in Vietnam. Drug Alcohol Rev. 2017; 37(3):333-339. PMC: 5794669. DOI: 10.1111/dar.12589. View

15.

Nong V, Boggiano V, Nguyen L, Nguyen C, Nguyen L, Bach T . Ability to join the workforce and work productivity among drug users under methadone maintenance treatment in a mountainous area of Northern Vietnam: a cross-sectional study. BMJ Open. 2017; 7(7):e016153. PMC: 5642751. DOI: 10.1136/bmjopen-2017-016153. View

16.

Herget G . Methadone and buprenorphine added to the WHO list of essential medicines. HIV AIDS Policy Law Rev. 2006; 10(3):23-4. View

17.

Jardine M, Nguyen V, Khuat T . Case study: Methadone maintenance treatment in Hanoi, Vietnam. Harm Reduct J. 2012; 9:26. PMC: 3423062. DOI: 10.1186/1477-7517-9-26. View

18.

Tran B, Nguyen L, Nong V, Nguyen C, Phan H, Latkin C . Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduct J. 2016; 13:4. PMC: 4736621. DOI: 10.1186/s12954-016-0091-4. View

19.

Hoang T, Ha T, Hoang T, Nhu N, Quoc N, Tam N . Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response. Harm Reduct J. 2015; 12:39. PMC: 4608299. DOI: 10.1186/s12954-015-0075-9. View

20.

Clarke S, Delamere S, McCullough L, Hopkins S, Bergin C, Mulcahy F . Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Med. 2003; 4(1):33-7. DOI: 10.1046/j.1468-1293.2003.00130.x. View